Hadassah

Hadassah Launches New Center for Treating Pediatric Vascular Defects

Tuesday, Apr 30 2013

The Hadassah Medical Organization has opened a multidisciplinary facility to treat pediatric vascular defects—a first for Israel. Ten percent of infants are born with vascular defects in various areas of the body. Vascular defects can develop while the child is still in utero and resulting symptoms can appear either at birth or later on during a child's adolescent years.

For most of these children, the defect will disappear within seven years; however, some may be left with scarring or aesthetic damage. Although only one percent of children born with vascular deformities need treatment to correct the defects in main arteries and airways, in many cases, the condition is not diagnosed correctly, which can prove life-threatening.

Until now, infants and children were sent abroad for corrective surgery. With the opening of the new center at Hadassah, these children can receive the same quality of treatment in Israel, as specialists from plastic surgery, dermatology, laryngology, diagnostic radiology, angiography, and invasive radiology combine their talents to build a comprehensive treatment plan.

"Today, we have access to minimally invasive measures for effective treatment," relates Dr. Adam Farkas of Hadassah's Vascular and Interventional Radiology Unit. "Early detection is the key, because it allows children to grow and develop well, both physically and socially, and to avoid unnecessary pain and suffering."

One method of treatment closes off the problematic blood vessels via insertion of a catheter through the groin. The area is cauterized until the vein or artery has shrunk to the point of blocking blood flow to the area, thus eventually causing it to disappear. The other treatment method is sclerotherapy, which also shrinks the problematic blood vessel, but with an injection of a special solution.

Dr. Farkas, age 32, who was born and raised in New York, recently immigrated to Israel with his wife and four children. He has a special interest in venous diseases and vascular malformations, for which he underwent specialized training at Boston (MA) Children's Hospital, an affiliate of Harvard Medical School. He has since brought to Hadassah some of the cutting-edge therapies he learned at Harvard.

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Tuesday, Apr 17 2018

Where are we with Stem Cells? Hadassah Pioneer Brings Us Up to Date

Many diseases involve the malfunctioning or dying of cells within the body.

READ MORE ›
alt_text

Tuesday, Apr 17 2018

Predicting Clinical Outcomes for Multiple Sclerosis Patients: Cutting-Edge Research at Hadassah

More than two million people--two to three times more women--have multiple sclerosis (MS)--the leading cause of neurological disability among young adults. What is their prognosis?

READ MORE ›
alt_text

Friday, Apr 13 2018

Hadassah Hospital Mount Scopus Hosts Conference to Mark Annual World Down Syndrome Day

Hadassah Hospital Mount Scopus hosted 200 people at the annual World Down Syndrome Day conference, held at the hospital in late March.

READ MORE ›
alt_text

Friday, Apr 13 2018

Hadassah Physicians Increase Number of Partial Thyroidectomies Following New ATA Guidelines

Following updated recommendations from the American Thyroid Association (ATA), Nir Hirschoren, M.D., of the Hadassah-Hebrew University Medical Center in Jerusalem...

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More